skip to content
Quantitative Biology
at the University of Delaware

Advisory Board

  1. Mission Statement

    The mission of the BS in Quantitative Biology (QBIO) Advisory Board is to provide ongoing evaluation of the appropriateness and effectiveness of the QBIO curriculum, to offer technical expertise and assistance in the design and use of classroom materials, and to help the faculty keep QBIO students aware of opportunities for off-campus research and future employment.

  2. Membership

    • Dr. Robert E. Akins, Ph.D., FAHA, Adjunct Associate Professor of Biological Sciences, UD; Adjunct Professor in Materials Science and Engineering, UD; Head, Tissue Engineering and Regenerative Medicine Research, A.I. DuPont Hospital for Children
    • Dr. Bruce Boman, M.D., Ph.D., M.S.P.H., FACP, Associate Scientist, Center for Translational Cancer Research; Director, Cancer Genetics and Stem Cell Biology, Helen F. Graham Cancer Center ; Professor of Medical Oncology, Thomas Jefferson University
    • Dr. James Bosley, Jr., Ph.D., PE, Principal, Rosa & Co, LLC, A Bio/Pharma Consultancy
    • Dr. Anastasia Christianson (Chair), Ph.D., Sr. Director and Global Skill Leader, Biomedical Informatics, AstraZeneca Pharmaceuticals
    • Dr. Kelvin H. Lee, Gore Professor of Chemical Engineering, UD; Director, Delaware Biotechnology Institute
    • Dr. Robert Leipold, Ph.D., Senior Principal Scientist, Pfizer